Experimental browser for the Atmosphere
Loading post...
{ "uri": "at://did:plc:pyqqzm3aysolbnh2mo4jjzuj/app.bsky.feed.like/3lp3wb3f4rf2b", "cid": "bafyreidlrwcf2n6lohb63mj66bbctxamurmin24x7u7wsku3iayrs32xa4", "value": { "$type": "app.bsky.feed.like", "subject": { "cid": "bafyreiaxouo3clcylfngsp23dqzswqgtu7pycbjtv6oxsa5legkdfvnr4u", "uri": "at://did:plc:k4jt6heuiamymgi46yeuxtpt/app.bsky.feed.post/3lp3qngnpb226" }, "createdAt": "2025-05-14T02:10:37.183Z" } }
Celgene kept the drug’s price low when it was initially intended for AIDS patients. But once the drug could be used more widely for cancer patients, the CEO told investors there was now “plenty of room for very substantial increases” in price. ➡️ Read more: propub.li/43jfFQF
May 14, 2025, 12:30 AM